The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference

Background The EQ-5D, a generic health status questionnaire that is widely used in health economic evaluation, was recently expanded to the EQ-5D-5L to address criticisms of unresponsiveness and ceiling effect. Aims To describe the validity, responsiveness and minimum important difference of the EQ-5D-5L in COPD. Methods Study 1: The validity of the EQ-5D-5L utility index and visual analogue scale (EQ-VAS) was compared with four established disease-specific health status questionnaires and other measures of disease severity in 616 stable outpatients with COPD. Study 2: The EQ-5D-5L utility index and EQ-VAS were measured in 324 patients with COPD before and after 8 weeks of pulmonary rehabilitation. Distribution and anchor-based approaches were used to estimate the minimum important difference. Results There were moderate-to-strong correlations between utility index and EQ-VAS with disease-specific questionnaires (Pearson's r=0.47–0.72). A ceiling effect was seen in 7% and 2.6% of utility index and EQ-VAS. Utility index decreased (worsening health status) with indices of worsening disease severity. With rehabilitation, mean (95% CI) changes in utility index and EQ-VAS were 0.065 (0.047 to 0.083) and 8.6 (6.5 to 10.7), respectively, with standardised response means of 0.39 and 0.44. The mean (range) anchor estimates of the minimum important difference for utility index and EQ-VAS were 0.051 (0.037 to 0.063) and 6.9 (6.5 to 8.0), respectively. Conclusions The EQ-5D-5L is a valid and responsive measure of health status in COPD and may provide useful additional cost-effectiveness data in clinical trials.

[1]  Karl Claxton,et al.  Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal. , 2016, Health economics.

[2]  S. Kon,et al.  Does pulmonary rehabilitation reduce peripheral blood pressure in patients with chronic obstructive pulmonary disease? , 2015, Chronic respiratory disease.

[3]  M. Thavorncharoensap,et al.  Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients , 2015, Health and Quality of Life Outcomes.

[4]  A. Spanevello,et al.  Estimation of Minimal Clinically Important Difference in EQ-5D Visual Analog Scale Score After Pulmonary Rehabilitation in Subjects With COPD , 2015, Respiratory Care.

[5]  S. Kon,et al.  Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation , 2014, Thorax.

[6]  W. Vollmer,et al.  Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form , 2014, BMC Medical Research Methodology.

[7]  Markus Lahtinen,et al.  Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population , 2014, Health and Quality of Life Outcomes.

[8]  Jing-jing Lv,et al.  Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B , 2014, Quality of Life Research.

[9]  S. Kon,et al.  Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. , 2014, The Lancet. Respiratory medicine.

[10]  John Newell,et al.  The cost-effectiveness of a structured education pulmonary rehabilitation programme for chronic obstructive pulmonary disease in primary care: the PRINCE cluster randomised trial , 2013, BMJ Open.

[11]  S. Kon,et al.  The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference , 2013, Thorax.

[12]  M. Jo,et al.  Psychometric properties of the EQ-5D-5L in the general population of South Korea , 2013, Quality of Life Research.

[13]  R. Werner,et al.  Assessing the value for money of pharmaceuticals in New Zealand--PHARMAC's approach to cost-utility analysis. , 2013, The New Zealand medical journal.

[14]  S. Kon,et al.  The five-repetition sit-to-stand test as a functional outcome measure in COPD , 2013, Thorax.

[15]  Nick Black,et al.  Patient reported outcome measures could help transform healthcare , 2013, BMJ.

[16]  Paul Cullinan,et al.  Reliability and validity of 4-metre gait speed in COPD , 2012, European Respiratory Journal.

[17]  T. Kohlmann,et al.  Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[18]  P. Jones,et al.  Utility Estimation in Chronic Obstructive Pulmonary Disease , 2011, PharmacoEconomics.

[19]  A. Pickard,et al.  Comparison of health-related quality of life measures in chronic obstructive pulmonary disease , 2011, Health and quality of life outcomes.

[20]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[21]  M. Bachmann,et al.  A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX). , 2010, Health technology assessment.

[22]  J. Treasure,et al.  A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. , 2010, Health technology assessment.

[23]  Ulrike Held,et al.  Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index , 2009, The Lancet.

[24]  P. Jones,et al.  Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study , 2009, European Respiratory Journal.

[25]  P. Lange,et al.  EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients. , 2008, Respiratory medicine.

[26]  A Simon Pickard,et al.  Use of a preference-based measure of health (EQ-5D) in COPD and asthma. , 2008, Respiratory medicine.

[27]  P. Jones,et al.  Outcomes and markers in the assessment of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[28]  John E. Brazier,et al.  Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D , 2005, Quality of Life Research.

[29]  Sally J. Singh,et al.  Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR) , 2001, Thorax.

[30]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[31]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[32]  M. S. Singh,et al.  Development of a shuttle walking test of disability in patients with chronic airways obstruction. , 1992, Thorax.

[33]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[34]  C. H. Wood,et al.  Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population , 1959, British medical journal.

[35]  L. Cipriano,et al.  Guidelines for the Economic Evaluation of Health Technologies: Canada , 2012 .

[36]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[37]  K. Stavem.  Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease , 2004, Quality of Life Research.

[38]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[39]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[40]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[41]  S. Jansson,et al.  Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD , 2003, Health and quality of life outcomes.